Osteonecrosis due to drugs, left fibula
ICD-10 M87.165 is a billable code used to indicate a diagnosis of osteonecrosis due to drugs, left fibula.
Osteonecrosis, also known as avascular necrosis, is a condition characterized by the death of bone tissue due to a lack of blood supply. In the case of M87.165, the osteonecrosis is specifically attributed to the use of certain medications, which can disrupt blood flow to the bone. This condition can lead to severe pain, limited mobility, and potential fractures. The left fibula, a long bone located in the lower leg, is affected in this instance. Osteonecrosis can occur in various bones, but the fibula is less commonly involved compared to the femur or humerus. Risk factors for drug-induced osteonecrosis include long-term use of corticosteroids, bisphosphonates, and certain chemotherapy agents. Clinically, patients may present with localized pain, swelling, and tenderness over the affected area. Imaging studies, such as MRI or X-rays, are essential for diagnosis, revealing changes in bone density and structure. Early intervention is crucial to prevent further complications, including the need for surgical procedures such as joint replacement or bone grafting.
Detailed notes on patient history, imaging results, and treatment plans.
Patients presenting with pain in the lower leg, particularly after prolonged corticosteroid use.
Ensure that all medications are documented, including dosages and duration of use.
Comprehensive assessment of underlying conditions and medication regimens.
Patients with autoimmune disorders requiring long-term immunosuppressive therapy.
Consideration of alternative diagnoses that may mimic osteonecrosis.
Used for pain management in patients with osteonecrosis.
Document the indication for the procedure and the patient's response.
Orthopedic specialists should note the specific joint involved.
Common medications include corticosteroids, bisphosphonates, and certain chemotherapy agents. It is crucial to document any long-term use of these drugs in patients diagnosed with osteonecrosis.
